Showing results (131-140 of 202) with videos related to

Sort By:
Pageof 21
Advances in Therapy|May 12, 2025
Real-World Evidence Acceptability and Use in Breast Cancer Treatment Decision-Making in the United States: Call-to-Action from a Multidisciplinary Think TankSean Khozin, Nancy A Dreyer, Dominic Galante, et al.
Future Oncology (London, England)|March 9, 2023
Prolonging the life of people with metastatic breast cancer in routine clinical practice by adding palbociclib to an aromatase inhibitor from a real-world database analysis: a plain language summaryHope S Rugo, Adam Brufsky, Xianchen Liu, et al.
Advances in Therapy|March 17, 2026
Clinically Meaningful, Patient-Centered Endpoints for Real-World Evidence Generation in Breast Cancer: Perspectives from the Multidisciplinary TRIUMPH InitiativeSean Khozin, Nancy A Dreyer, Dominic Galante, et al.
NPJ Breast Cancer|October 11, 2022
Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancerHope S Rugo, Adam Brufsky, Xianchen Liu, et al.
JCO Global Oncology|April 11, 2022
Clinical Benefit of Comprehensive Genomic Profiling for Advanced Cancers in IndiaAju Mathew, Serena Joseph, Jeffrey Boby, et al.
European Journal of Breast Health|June 19, 2026
Survivor Perspectives on Artificial Intelligence Integration in Breast Cancer Treatment: A Qualitative Study of Trust, Equity, and ApplicationPeggy Rosenzweig, Margaret Quinn Rosenzweig, Xueying Pei, et al.
The Oncologist|May 26, 2021
Prognostic Factors for Overall Survival in Patients with Hormone Receptor-Positive Advanced Breast Cancer: Analyses From PALOMA-3Hope S Rugo, Massimo Cristofanilli, Sybille Loibl, et al.
The Journal of Pain|July 30, 2013
Persistent postmastectomy pain in breast cancer survivors: analysis of clinical, demographic, and psychosocial factorsInna Belfer, Kristin L Schreiber, John R Shaffer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in metastatic and locally advanced breast cancerJennifer A Low, Suparna B Wedam, James J Lee, et al.
Breast Cancer : Basic and Clinical Research|August 6, 2020
Outcome of Everolimus-Based Therapy in Hormone-Receptor-Positive Metastatic Breast Cancer Patients After Progression on PalbociclibAjay Dhakal, Roby Antony Thomas, Ellis G Levine, et al.
Pageof 21